Aktas B - Search Results

1

Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.

Aktas B, Utz A, Hoenig-Liedl P, Walter U, Geiger J. Aktas B, et al. Stroke. 2003 Mar;34(3):764-9. doi: 10.1161/01.STR.0000056527.34434.59. Epub 2003 Jan 30. Stroke. 2003. PMID: 12624305 Clinical Trial.

2

Inhibition of platelet P2Y12 and alpha2A receptor signaling by cGMP-dependent protein kinase.

Aktas B, Hönig-Liedl P, Walter U, Geiger J. Aktas B, et al. Biochem Pharmacol. 2002 Aug 1;64(3):433-9. doi: 10.1016/s0006-2952(02)01113-9. Biochem Pharmacol. 2002. PMID: 12147294

3

Monitoring of clopidogrel action: comparison of methods.

Geiger J, Teichmann L, Grossmann R, Aktas B, Steigerwald U, Walter U, Schinzel R. Geiger J, et al. Among authors: aktas b. Clin Chem. 2005 Jun;51(6):957-65. doi: 10.1373/clinchem.2004.047050. Epub 2005 Apr 7. Clin Chem. 2005. PMID: 15817818 Clinical Trial.

4

Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway.

Begonja AJ, Gambaryan S, Geiger J, Aktas B, Pozgajova M, Nieswandt B, Walter U. Begonja AJ, et al. Among authors: aktas b. Blood. 2005 Oct 15;106(8):2757-60. doi: 10.1182/blood-2005-03-1047. Epub 2005 Jun 23. Blood. 2005. PMID: 15976180 Free article.

5

Platelets in atherothrombosis: lessons from mouse models.

Nieswandt B, Aktas B, Moers A, Sachs UJ. Nieswandt B, et al. Among authors: aktas b. J Thromb Haemost. 2005 Aug;3(8):1725-36. doi: 10.1111/j.1538-7836.2005.01488.x. J Thromb Haemost. 2005. PMID: 16102039 Free article. Review.

6

The C-terminal peptide of thrombospondin-1 stimulates distinct signaling pathways but induces an activation-independent agglutination of platelets and other cells.

Voit S, Udelhoven M, Lill G, Aktas B, Nieswandt B, Schrör K, Weber AA. Voit S, et al. Among authors: aktas b. FEBS Lett. 2003 Jun 5;544(1-3):240-5. doi: 10.1016/s0014-5793(03)00472-1. FEBS Lett. 2003. PMID: 12782324 Free article.

7

Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor.

Schulte V, Rabie T, Prostredna M, Aktas B, Grüner S, Nieswandt B. Schulte V, et al. Among authors: aktas b. Blood. 2003 May 15;101(10):3948-52. doi: 10.1182/blood-2002-10-3242. Epub 2003 Jan 16. Blood. 2003. PMID: 12531795 Free article.

8

Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.

Grüner S, Prostredna M, Aktas B, Moers A, Schulte V, Krieg T, Offermanns S, Eckes B, Nieswandt B. Grüner S, et al. Among authors: aktas b. Circulation. 2004 Nov 2;110(18):2946-51. doi: 10.1161/01.CIR.0000146341.63677.3C. Epub 2004 Oct 25. Circulation. 2004. PMID: 15505105

9

Aspirin induces platelet receptor shedding via ADAM17 (TACE).

Aktas B, Pozgajova M, Bergmeier W, Sunnarborg S, Offermanns S, Lee D, Wagner DD, Nieswandt B. Aktas B, et al. J Biol Chem. 2005 Dec 2;280(48):39716-22. doi: 10.1074/jbc.M507762200. Epub 2005 Sep 22. J Biol Chem. 2005. PMID: 16179345 Free article.

10

G13 is an essential mediator of platelet activation in hemostasis and thrombosis.

Moers A, Nieswandt B, Massberg S, Wettschureck N, Grüner S, Konrad I, Schulte V, Aktas B, Gratacap MP, Simon MI, Gawaz M, Offermanns S. Moers A, et al. Among authors: aktas b. Nat Med. 2003 Nov;9(11):1418-22. doi: 10.1038/nm943. Epub 2003 Oct 5. Nat Med. 2003. PMID: 14528298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters